Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine QL Block vs QL2 Block for Post-operative Analgesia
NCT03100994Phase 4Unknown
- Sponsor
- Tri-Service General Hospital
- Start
- Mar 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by Tri-Service General Hospital. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03100994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03100994.